Downregulation of microRNA miR-520h by E1A contributes to anticancer activity

JL Su, PB Chen, YH Chen, SC Chen, YW Chang… - Cancer research, 2010 - AACR
JL Su, PB Chen, YH Chen, SC Chen, YW Chang, YH Jan, X Cheng, M Hsiao, MC Hung
Cancer research, 2010AACR
The leading cause of death in cancer patients is cancer metastasis, for which there is no
effective treatment. MicroRNAs (miRNA) have been shown to play a significant role in
cancer metastasis through regulation of gene expression. The adenovirus type 5 E1A (E1A)
is associated with multiple tumor-suppressing activities including the inhibition of metastasis,
and E1A gene therapies have been tested in several clinical trials. However, the
mechanisms involved in E1A-mediated tumor-suppressing activities are not yet completely …
Abstract
The leading cause of death in cancer patients is cancer metastasis, for which there is no effective treatment. MicroRNAs (miRNA) have been shown to play a significant role in cancer metastasis through regulation of gene expression. The adenovirus type 5 E1A (E1A) is associated with multiple tumor-suppressing activities including the inhibition of metastasis, and E1A gene therapies have been tested in several clinical trials. However, the mechanisms involved in E1A-mediated tumor-suppressing activities are not yet completely defined. Here, we showed that E1A downregulated the expression of the miRNA miR-520h, which was critical for E1A-mediated cancer cell mobility and in vitro invasion activity. In addition, we identified a signal cascade, namely, E1A→miRNA-520h→PP2A/C→IκB kinase→NF-κB→Twist, in which E1A inhibited the expression of Twist through downregulation of miR-520h and the signal cascade. Our results indicated a functional link between miR-520h and tumorigenicity/invasive ability and provided a new insight into the role of E1A-mediated miRNA regulation in tumor suppression. Therefore, the results identified a new cascade of E1A-mediated tumor suppression activity via downregulation of miRNA-520h expression. Cancer Res; 70(12); 5096–108. ©2010 AACR.
AACR